Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting.

Journal of psychiatric research - 1 Sept 2008

Alenius Malin, Wadelius Mia, Dahl Marja-Liisa, Hartvig Per, Lindström Leif, Hammarlund-Udenaes Margareta

Abstract excerpt

RATIONALE: Many patients with psychotic symptoms respond poorly to treatment. Factors possibly affecting treatment response include the presence of polymorphisms in genes coding for various receptor populations, drug-metabolizing enzymes or transport proteins. OBJECTIVES: To investigate whether genetic polymorphisms could be indicators of treatment response to antipsychotic drugs. The genes of interest were the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to ATP Binding Cassette Transporter, Subfamily B

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Benzodiazepines

Share to Needs Assessment

Share to Olanzapine

Share to Receptor, Serotonin, 5-HT2A

Share to Receptor, Serotonin, 5-HT2C

Share to Schizophrenia, Paranoid

Source

Identifiers

PMID: 18086475
DOI: 10.1016/j.jpsychires.2007.10.007

Genes

DRD2
ABCB1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting.PMID 18086475Read ↗

ABCB1 and CYP2D6 polymorphisms and treatment response of psychotic patients in a naturalistic setting.Semantic proximity Read ↗

Clinical response to antipsychotic drug treatment: association study of polymorphisms in six candidate genes.Semantic proximity Read ↗

Contribution of allelic variations to the phenotype of response to antidepressants and antipsychotics.Semantic proximity Read ↗

D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis.Semantic proximity Read ↗

Exploring pharmacogenetic variation in a Bulgarian psychiatric cohort.Semantic proximity Read ↗

Treatment Response and GWAS Risk Allele rs2514218 (C) of the Dopamine D2 Receptor Gene in Inpatients with Schizophrenia.Semantic proximity Read ↗

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.Semantic proximity Read ↗

The pharmacogenetics of treatment with olanzapineSemantic proximity Read ↗

Association of Genetic Variants of Dopamine and Serotonin In Schizophrenia.Semantic proximity Read ↗

Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia.Semantic proximity Read ↗

Pharmacogenetics of second-generation antipsychotics.Semantic proximity Read ↗

CYP1A2*1D and *1F polymorphisms have a significant impact on olanzapine serum concentrations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.